Literature DB >> 15076175

Uric acid, endothelial dysfunction and pre-eclampsia: searching for a pathogenetic link.

Duk-Hee Kang1, Jennifer Finch, Takahiko Nakagawa, S Ananth Karumanchi, John Kanellis, Joey Granger, Richard J Johnson.   

Abstract

BACKGROUND: Pre-eclampsia is strongly associated with hyperuricemia, and in some studies the increase in serum uric acid has been found to correlate with both maternal and fetal morbidity. The hyperuricemia is believed to result primarily from the decreased renal excretion that occurs as a consequence of the pre-eclampsia, and as such is widely viewed as a marker for pre-eclampsia as opposed to having a role in the pathogenesis. HYPOTHESIS: We present the hypothesis that hyperuricemia may also have a contributory role in the development of hypertension and renal disease in these patients, and we review recent experimental data that would support this hypothesis. RECOMMENDATION: We suggest that studies addressing the role of uric acid in pre-eclampsia may provide new insights into both the pathogenesis and treatment of this condition.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15076175     DOI: 10.1097/00004872-200402000-00001

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  25 in total

1.  Uric acid inhibits placental system A amino acid uptake.

Authors:  S A Bainbridge; F von Versen-Höynck; J M Roberts
Journal:  Placenta       Date:  2008-12-05       Impact factor: 3.481

2.  Serum uric acid may not be involved in the development of preeclampsia.

Authors:  Q Chen; S Lau; M Tong; J Wei; F Shen; J Zhao; M Zhao
Journal:  J Hum Hypertens       Date:  2015-05-21       Impact factor: 3.012

Review 3.  Hyperuricemia and Hypertension: Links and Risks.

Authors:  Douglas J Stewart; Valerie Langlois; Damien Noone
Journal:  Integr Blood Press Control       Date:  2019-12-24

4.  Maternal serum uric acid concentration is associated with the expression of tumour necrosis factor-α and intercellular adhesion molecule-1 in patients with preeclampsia.

Authors:  J Zhao; D-Y Zheng; J-M Yang; M Wang; X-T Zhang; L Sun; X-G Yun
Journal:  J Hum Hypertens       Date:  2015-10-29       Impact factor: 3.012

5.  Diagnostic utility of heat stable alkaline phosphatase in hypertensive disorders of pregnancy.

Authors:  Reeta Rajagambeeram; Srinivasan Abu Raghavan; Seethesh Ghosh; Sharbari Basu; Ramesh Ramasamy; Sathish Babu Murugaiyan
Journal:  J Clin Diagn Res       Date:  2014-11-20

6.  Uric acid: is it time to give up routine testing in management of pre-eclampsia?

Authors:  Vikram Sinai Talaulikar; Hassan Shehata
Journal:  Obstet Med       Date:  2012-03-29

7.  Triuret as a potential hypokalemic agent: Structure characterization of triuret and triuret-alkali metal adducts by mass spectrometric techniques.

Authors:  Sergiu P Palii; Cesar S Contreras; Jeffrey D Steill; Stela S Palii; Jos Oomens; John R Eyler
Journal:  Arch Biochem Biophys       Date:  2010-04-03       Impact factor: 4.013

8.  Uric acid: a clinically useful marker to distinguish preeclampsia from gestational hypertension.

Authors:  Richard J Johnson; Mehmet Kanbay; Duk-Hee Kang; Laura Gabriela Sánchez-Lozada; Daniel Feig
Journal:  Hypertension       Date:  2011-08-29       Impact factor: 10.190

9.  Uric acid attenuates trophoblast invasion and integration into endothelial cell monolayers.

Authors:  Shannon A Bainbridge; James M Roberts; Frauke von Versen-Höynck; Jessa Koch; Lia Edmunds; Carl A Hubel
Journal:  Am J Physiol Cell Physiol       Date:  2009-06-17       Impact factor: 4.249

Review 10.  Uric acid as a pathogenic factor in preeclampsia.

Authors:  S A Bainbridge; J M Roberts
Journal:  Placenta       Date:  2008-02-21       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.